Study S001746

Myocardial Metabolic Flux in Patients With Pulmonary Arterial Hypertension (PAH) in Response to GLP-1 Agonist Therapy: a Physiological Study Using 31-Phosphorus MR Spectroscopy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07737522
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 32
Start: 2026-10-01
Primary completion: 2028-10-01
Lead sponsor: Imperial College London
Conditions: Pulmonary Arterial Hypertension
Interventions: DRUG:GLP-1 agonist
Results posted: FALSE

Registered primary outcomes

Change in the phosphocreatine-to-adenosine triphosphate (31PCr/ATP) ratio between baseline and follow up in response to treatment with GLP-1 agonist [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.